![Prospective Identification of Oligoclonal/Abnormal Band of the Same Immunoglobulin Type as the Malignant Clone by Differential Location of M-Spike and Oligoclonal Band. - Abstract - Europe PMC Prospective Identification of Oligoclonal/Abnormal Band of the Same Immunoglobulin Type as the Malignant Clone by Differential Location of M-Spike and Oligoclonal Band. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5593429/bin/jocmr-09-826-g001.jpg)
Prospective Identification of Oligoclonal/Abnormal Band of the Same Immunoglobulin Type as the Malignant Clone by Differential Location of M-Spike and Oligoclonal Band. - Abstract - Europe PMC
![Serum immunofixation electrophoresis revealed an IgG kappa monoclonal... | Download Scientific Diagram Serum immunofixation electrophoresis revealed an IgG kappa monoclonal... | Download Scientific Diagram](https://www.researchgate.net/publication/319053468/figure/fig3/AS:526069440540672@1502436136379/Serum-immunofixation-electrophoresis-revealed-an-IgG-kappa-monoclonal-proteinFigure-2A.png)
Serum immunofixation electrophoresis revealed an IgG kappa monoclonal... | Download Scientific Diagram
![Diagnostics | Free Full-Text | Complete Depletion of Daratumumab Interference in Serum Samples from Plasma Cell Myeloma Patients Improves the Detection of Endogenous M-Proteins in a Preliminary Study Diagnostics | Free Full-Text | Complete Depletion of Daratumumab Interference in Serum Samples from Plasma Cell Myeloma Patients Improves the Detection of Endogenous M-Proteins in a Preliminary Study](https://www.mdpi.com/diagnostics/diagnostics-10-00219/article_deploy/html/images/diagnostics-10-00219-g003.png)
Diagnostics | Free Full-Text | Complete Depletion of Daratumumab Interference in Serum Samples from Plasma Cell Myeloma Patients Improves the Detection of Endogenous M-Proteins in a Preliminary Study
![Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference](https://www.degruyter.com/document/doi/10.1515/cclm-2021-0399/asset/graphic/j_cclm-2021-0399_fig_002.jpg)
Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference
![SPEP and SIFE in April 2017. The original malignant IgG kappa clone is... | Download Scientific Diagram SPEP and SIFE in April 2017. The original malignant IgG kappa clone is... | Download Scientific Diagram](https://www.researchgate.net/publication/319436469/figure/fig2/AS:533976655437824@1504321363370/SPEP-and-SIFE-in-April-2017-The-original-malignant-IgG-kappa-clone-is-absent-on-both.png)
SPEP and SIFE in April 2017. The original malignant IgG kappa clone is... | Download Scientific Diagram
![Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference](https://www.degruyter.com/document/doi/10.1515/cclm-2021-0399/asset/graphic/j_cclm-2021-0399_fig_003.jpg)
Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference
![Immunoglobulin G kappa biclonal gammopathy associated with multiple myeloma, plasmacytoma and cast nephropathy Immunoglobulin G kappa biclonal gammopathy associated with multiple myeloma, plasmacytoma and cast nephropathy](https://cancerjournal.net/articles/2015/11/3/images/JCanResTher_2015_11_3_660_139379_f6.jpg)